|
Volumn 35, Issue 1, 2010, Pages 96-
|
High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DAPTOMYCIN;
METICILLIN;
POLYPEPTIDE ANTIBIOTIC AGENT;
RIFAMPICIN;
VANCOMYCIN;
ABSENCE OF SIDE EFFECTS;
AGED;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTEREMIA;
BACTERIAL ENDOCARDITIS;
BACTERIAL GROWTH;
BLOOD CULTURE;
BROTH DILUTION;
CASE REPORT;
DRUG DOSE INCREASE;
DRUG MEGADOSE;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
EARLY INTERVENTION;
FEVER;
HUMAN;
LETTER;
MALE;
MEDICAL DECISION MAKING;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
OFF LABEL DRUG USE;
PRIORITY JOURNAL;
STAPHYLOCOCCUS AUREUS;
TRANSTHORACIC ECHOCARDIOGRAPHY;
TREATMENT OUTCOME;
ANTI-BACTERIAL AGENTS;
DAPTOMYCIN;
DRUG RESISTANCE, BACTERIAL;
ENDOCARDITIS, BACTERIAL;
GLYCOPEPTIDES;
HUMANS;
STAPHYLOCOCCAL INFECTIONS;
|
EID: 70949097897
PISSN: 09248579
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2009.08.019 Document Type: Letter |
Times cited : (14)
|
References (4)
|